As the above studies initially confirmed the correlation of ERLIN2 and CDK5RAP3 with the PCa-immune microenvironment and immunotherapy, the study delved into the correlation between prognostic subgroups based on ERLIN2-CDK5RAP3 with tumor immunity. This evidence concerns the gene CDK5RAP3 and neoplasm.